1.Automatic detection and clinical application of semen biochemical markers.
National Journal of Andrology 2018;24(4):291-296
Human seminal plasma is rich in potential biological markers for male infertility and male reproductive system diseases, which have an application value in the diagnosis and treatment of male infertility. The methods for the detection of semen biochemical markers have been developed from the manual, semi-automatic to the present automatic means. The automatic detection of semen biochemical markers is known for its advantages of simple reagent composition and small amount of reagents for each test, simple setting of parameters, whole automatic procedure with few errors, short detection time contributive to batch detection and reduction of manpower cost, simple calibration and quality control procedure to ensure accurate and reliable results, output of results in the order of the samples in favor of clinical diagnosis and treatment, and open reagents applicable to various automatic biochemistry analyzers. At present, the automatic method is applied in the detection of such semen biochemical markers as seminal plasma total and neutral alpha-glucosidase, acid phosphatase, fructose, γ-glutamyl transpeptidase, zinc, citric acid, uric acid, superoxide dismutase and carnitine, sperm acrosin and lactate dehydrogenase C4, and semen free elastase, which can be used to evaluate the secretory functions of the epididymis, seminal vesicle and prostate, sperm acrosome and energy metabolism function, seminal plasma antioxidative function, and infection or silent infection in the male genital tract.
Acid Phosphatase
;
analysis
;
Biomarkers
;
analysis
;
Carnitine
;
analysis
;
Citric Acid
;
analysis
;
Epididymis
;
metabolism
;
Fructose
;
analysis
;
Humans
;
Infertility, Male
;
diagnosis
;
Isoenzymes
;
L-Lactate Dehydrogenase
;
Male
;
Prostate
;
metabolism
;
Semen
;
chemistry
;
Seminal Vesicles
;
Spermatozoa
;
chemistry
;
alpha-Glucosidases
;
analysis
;
gamma-Glutamyltransferase
;
analysis
2.Effects of traditional herbal formulae on human CYP450 isozymes.
Seong Eun JIN ; Hyekyung HA ; Hyeun-Kyoo SHIN
Chinese journal of integrative medicine 2017;23(1):62-69
OBJECTIVETo assess the effects of traditional herbal formulae Sijunzi Decoction (, Sagunja-tang, SJZD), Siwu Decoction (, Samul-tang, SWD), Bawu Decoction (, Palmul-tang, BWD) and Shiquan Dabu Decoction (, Sipjeondaebo-tang, SDD) on the activities of human cytochrome P450 (CYP450), a drug-metabolizing enzyme.
METHODSHerbal formula water extracts were filtered and lyophilized after the powder extracts were dissolved in distilled water. The activities of major human CYP450 isozymes (CYP3A4, CYP2C19, CYP2D6 and CYP2E1) were measured using in vitro fluorescence-based enzyme assays. The inhibitory effects of the herbal formulas on the activities of CYP450 were characterized as half maximal inhibition concentration (IC) values.
RESULTSAll the tested herbal formulae inhibited CYP2C19 activity (IC: SJZD, 83.28 μg/mL; SWD, 235.54 μg/mL; BWD, 166.82 μg/mL; SDD, 178.19 μg/mL); SJZD (IC= 196.46 μg/mL), SWD (IC= 333.42 μg/mL) and SDD (IC= 163.42 μg/mL) inhibited CYP2E1-mediated metabolism; whereas BWD exhibited comparatively weak inhibition of CYP2E1 (IC= 501.78 μg/mL). None of the four herbal formulas significantly affected CYP3A4 or CYP2D6.
CONCLUSIONSThese results suggest that SJZD, SWD, BWD and SDD could potentially inhibit the metabolism of co-administered synthetic drugs whose primary route of elimination is via CYP2C19. In addition, clinically relevant pharmacokinetic interactions could occur when SJZD, SWD or SDD is co-administered with drugs metabolized by CYP2E1. Our findings provide information for the safety and effective clinical use of these four classic herbal formulas.
Cytochrome P-450 Enzyme System ; metabolism ; Drugs, Chinese Herbal ; pharmacology ; Hot Temperature ; Humans ; Inhibitory Concentration 50 ; Isoenzymes ; metabolism ; Plant Extracts ; pharmacology ; Water ; chemistry
3.Expression of ALDH1, CXCR4 and E-cadherin in castric carcinoma and their roles in lymphatic metastasis.
Yan ZHAO ; Xin JIN ; Nan LI ; Jing LI ; Jun QIAN
Journal of Southern Medical University 2016;36(10):1390-1395
OBJECTIVETo investigate the expression of ALDH1, CXCR4 and E-cadherin in gastric carcinoma and their roles in lymphatic metastasis.
METHODSSurgical specimens from 127 cases of gastric carcinoma were examined for expressions of ALDH1, CXCR4 and E-cadherin immuohistochemistry with 60 adjacent tissues as control. The associations of ALDH1, CXCR4 and E-cadherin with the clinicopathological pfeatures, 5-year survival rate and lymph node metastasis of the patients were analyzed.
RESULTSALDH1, CXCR4 and E-cadherin were positive in 57.5% (73/127), 63.8% (81/127), and 36.2% (46/127) of the gastric carcinoma tissues, respectively, showing significant differences from the rates in the adjacent tissues (P<0.05). The expression of ALDH1 was significantly correlated with TNM stage and lymph node metastasis (P<0.05), CXCR4 was significantly correlated with the invasion depth, differentiation, TNM stage and lymph node metastasis of the tumor (P<0.05), and E-cadherin was significantly correlated with the invasion depth, differentiation and lymph node metastasis (P<0.05). The positivity rates of ALDH1, CXCR4 and E-cadherin were higher in cases with lymph node metastasis than in those without metastasis. E-cadherin expression was inversely correlated with ALDH1 and CXCR4 expression, and the latter two were positively correlated (P<0.001). Overexpressions of ALDH1 and CXCR4 and a decreased expression of E-cadherin were all related to a poor prognosis of the patients (P<0.05). The expressions ofALDH1, CXCR4 and E-cadherin were all independent prognostic factors of gastric carcinoma.
CONCLUSIONThe expressions of ALDH1, CXCR4 and E-cadherin are associated with the invasion, metastasis and prognosis of gastric carcinoma, and their combined detection provides important evidence for predicting the progression and prognosis of gastric carcinoma.
Cadherins ; genetics ; metabolism ; Carcinoma ; genetics ; metabolism ; Disease Progression ; Humans ; Isoenzymes ; genetics ; metabolism ; Lymphatic Metastasis ; Prognosis ; Receptors, CXCR4 ; genetics ; metabolism ; Retinal Dehydrogenase ; genetics ; metabolism ; Stomach Neoplasms ; genetics ; metabolism ; Survival Rate
4.RNA-binding protein PTB in spermatogenesis: Progress in studies.
Xian-Ming DOU ; Xian-Sheng ZHANG
National Journal of Andrology 2016;22(9):856-860
RNA binding proteins (RBPs) regulate the function of cells by interacting with nascent transcripts and therefore are receiving increasing attention from researchers for their roles in tissue development and homeostasis. The polypyrimidine tract binding (PTB) protein family of RBPs are important posttranscriptional regulators of gene expression. Further investigations on the post-transcriptional regulation mechanisms and isoforms of PTB proteins in the spermatogenesis show that PTB protein 1 (Ptbp1) is a predominant isoform in mitotic cells (spermatogonia), while Ptbp2 predominates in meiotic spermatocytes and postmeiotic spermatids and binds to the specific 3' untranslated region (3' UTR) of the phosphoglycerate kinase 2 (Pgk-2) mRNA, which helps to stabilize Pgk-2 mRNA in male mouse germ cells. In case of Ptbp2 inactivation in the testis, the differentiation of germ cells arrests in the stage of round spermatids, with proliferation of multinucleated cells in the seminiferous tubule, increased apoptosis of spermatocytes, atrophy of seminiferous tubules, and lack of elongating spermatids, which consequently affects male fertility. This article presents an overview on the structure of the PTB protein and its role in regulating mammalian spermatogenesis.
Animals
;
Atrophy
;
Gene Expression Regulation
;
physiology
;
Heterogeneous-Nuclear Ribonucleoproteins
;
metabolism
;
physiology
;
Homeostasis
;
Isoenzymes
;
metabolism
;
Male
;
Mice
;
Nerve Tissue Proteins
;
metabolism
;
physiology
;
Phosphoglycerate Kinase
;
metabolism
;
Polypyrimidine Tract-Binding Protein
;
metabolism
;
physiology
;
RNA, Messenger
;
metabolism
;
RNA-Binding Proteins
;
Seminiferous Tubules
;
pathology
;
Spermatids
;
metabolism
;
Spermatocytes
;
metabolism
;
Spermatogenesis
;
physiology
;
Spermatogonia
;
metabolism
;
Testis
;
metabolism
5.Aldehyde dehydrogenase is used by cancer cells for energy metabolism.
Joon Hee KANG ; Seon Hyeong LEE ; Dongwan HONG ; Jae Seon LEE ; Hee Sung AHN ; Ju Hyun AHN ; Tae Wha SEONG ; Chang Hun LEE ; Hyonchol JANG ; Kyeong Man HONG ; Cheolju LEE ; Jae Ho LEE ; Soo Youl KIM
Experimental & Molecular Medicine 2016;48(11):e272-
We found that non-small-cell lung cancer (NSCLC) cells express high levels of multiple aldehyde dehydrogenase (ALDH) isoforms via an informatics analysis of metabolic enzymes in NSCLC and immunohistochemical staining of NSCLC clinical tumor samples. Using a multiple reaction-monitoring mass spectrometry analysis, we found that multiple ALDH isozymes were generally abundant in NSCLC cells compared with their levels in normal IMR-90 human lung cells. As a result of the catalytic reaction mediated by ALDH, NADH is produced as a by-product from the conversion of aldehyde to carboxylic acid. We hypothesized that the NADH produced by ALDH may be a reliable energy source for ATP production in NSCLC. This study revealed that NADH production by ALDH contributes significantly to ATP production in NSCLC. Furthermore, gossypol, a pan-ALDH inhibitor, markedly reduced the level of ATP. Gossypol combined with phenformin synergistically reduced the ATP levels, which efficiently induced cell death following cell cycle arrest.
Adenosine Triphosphate
;
Aldehyde Dehydrogenase*
;
Cell Cycle Checkpoints
;
Cell Death
;
Energy Metabolism*
;
Gossypol
;
Humans
;
Informatics
;
Isoenzymes
;
Lung
;
Lung Neoplasms
;
Mass Spectrometry
;
NAD
;
Phenformin
;
Protein Isoforms
6.Expression of lactate dehydrogenase-5 in non-Hodgkin lymphoma and its clinical significance.
Fei DONG ; Aixia SUI ; Hongmei JING
Journal of Central South University(Medical Sciences) 2016;41(12):1312-1316
To determine expression of lactate dehydrogenase (LDH)-5 in non-Hodgkin lymphoma and its clinical significance.
Methods: LDH-5 levels and LDH levels in NHL patients were examined by agarose gel electrophoresis and enzymatic method (n=63), respectively. Positive rates of LDH-5 and LDH were statistically analyzed.
Results: The median age of NHL patients was 56(19-84) years old, including 36 males and 27 females. The positive numbers for LDH-5 and LDH in the initial treatment group (n=43) were significantly different (P<0.05). There was significant difference in 22 cases of diffuse large B cell lymphoma and in 9 cases of T cell lymphoma, whereas there was not significant difference in 12 cases of small B cell lymphoma (P>0.05). In 15 cases under the status of progress, the difference of LDH-5 and LDH expressions were not significant (P>0.05), whereas the difference in cases of small B cell lymphoma was significant (P<0.05).
Conclusion: LDH-5 can be used as an index for NHL to judge the tumor load and to predict the recurrence.
Adult
;
Aged
;
Aged, 80 and over
;
Biomarkers, Tumor
;
blood
;
metabolism
;
Female
;
Humans
;
Isoenzymes
;
metabolism
;
L-Lactate Dehydrogenase
;
metabolism
;
Lactate Dehydrogenase 5
;
Lymphoma, B-Cell
;
genetics
;
Lymphoma, Large B-Cell, Diffuse
;
genetics
;
Lymphoma, Non-Hodgkin
;
genetics
;
Lymphoma, T-Cell
;
genetics
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local
;
genetics
;
Prognosis
;
Tumor Burden
7.Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers.
Diabetes & Metabolism Journal 2015;39(3):188-197
Impaired glucose homeostasis is one of the risk factors for causing metabolic diseases including obesity, type 2 diabetes, and cancers. In glucose metabolism, pyruvate dehydrogenase complex (PDC) mediates a major regulatory step, an irreversible reaction of oxidative decarboxylation of pyruvate to acetyl-CoA. Tight control of PDC is critical because it plays a key role in glucose disposal. PDC activity is tightly regulated using phosphorylation by pyruvate dehydrogenase kinases (PDK1 to 4) and pyruvate dehydrogenase phosphatases (PDP1 and 2). PDKs and PDPs exhibit unique tissue expression patterns, kinetic properties, and sensitivities to regulatory molecules. During the last decades, the up-regulation of PDKs has been observed in the tissues of patients and mammals with metabolic diseases, which suggests that the inhibition of these kinases may have beneficial effects for treating metabolic diseases. This review summarizes the recent advances in the role of specific PDK isoenzymes on the induction of metabolic diseases and describes the effects of PDK inhibition on the prevention of metabolic diseases using pharmacological inhibitors. Based on these reports, PDK isoenzymes are strong therapeutic targets for preventing and treating metabolic diseases.
Acetyl Coenzyme A
;
Decarboxylation
;
Diabetes Mellitus, Type 2
;
Glucose
;
Homeostasis
;
Humans
;
Isoenzymes
;
Mammals
;
Metabolic Diseases
;
Metabolism
;
Obesity
;
Oxidoreductases*
;
Phosphoric Monoester Hydrolases
;
Phosphorylation
;
Phosphotransferases*
;
Pyruvate Dehydrogenase Complex
;
Pyruvic Acid*
;
Risk Factors
;
Up-Regulation
8.The expression of the sperm-specific lactate dehydrogenase gene Ldh-c in plateau pika (Ochotona curzoniae) cardiac muscle and its effect on the anaerobic glycolysis.
Xiao LI ; Lian WEI ; Yang WANG ; Li-Na XU ; Lin-Na WEI ; Deng-Bang WEI
Acta Physiologica Sinica 2015;67(3):312-318
The plateau pika (Ochotona curzoniae) has a strong adaptability to hypoxic plateau environment. We found that the sperm-specific lactate dehydrogenase (LDH-C4) gene Ldh-c expressed in plateau pika cardiac muscle. In order to shed light on the effect of LDH-C4 on the anaerobic glycolysis in plateau pika cardiac muscle, 20 pikas were randomly divided into the inhibitor group and the control group, and the sample size of each group was 10. The pikas of inhibitor group were injected with 1 mL 1 mol/L N-isopropyl oxamate, a specific LDH-C4 inhibitor, in biceps femoris muscle of hind legs, each leg with 500 μL. The pikas of control group were injected with the same volume of normal saline (0.9% NaCl). The mRNA and protein expression levels of Ldh-c gene in plateau pika cardiac muscle were determined by real-time PCR and Western blot. The activities of LDH, and the contents of lactate (LD) and ATP in cardiac muscle were compared between the inhibitor group and the control group. The results showed that 1) the expression levels of Ldh-c mRNA and protein were 0.47 ± 0.06 and 0.68 ± 0.08, respectively; 2) 30 min after injection of 1 mL 1 mol/L N-isopropyl oxamate in biceps femoris muscle, the concentration of N-isopropyl oxamate in blood was 0.08 mmol/L; 3) in cardiac muscle of the inhibitor group and the control group, the LDH activities were (6.18 ± 0.48) U/mg and (9.08 ± 0.58) U/mg, the contents of LD were (0.21 ± 0.03) mmol/g and (0.26 ± 0.04) mmol/g, and the contents of ATP were (4.40 ± 0.69) nmol/mg and (6.18 ± 0.73) nmol/mg (P < 0.01); 5) the inhibition rates of N-isopropyl oxamate to LDH, LD and ATP were 31.98%, 20.90% and 28.70%, respectively. The results suggest that Ldh-c expresses in cardiac muscle of plateau pika, and the pika cardiac muscle may get at least 28% ATP for its activities by LDH-C4 catalyzed anaerobic glycolysis, which reduces the dependence on oxygen and enhances the adaptation to the hypoxic environments.
Acclimatization
;
Animals
;
Glycolysis
;
Hypoxia
;
Isoenzymes
;
genetics
;
metabolism
;
L-Lactate Dehydrogenase
;
genetics
;
metabolism
;
Lactic Acid
;
analysis
;
Lagomorpha
;
genetics
;
Male
;
Myocardium
;
enzymology
;
Oxamic Acid
;
analogs & derivatives
;
Oxygen
;
RNA, Messenger
9.Interaction of butylphthalide with rat and human liver CYP450 isoenzymes.
Qian ZHAO ; Jin-ping HU ; Ji JIANG ; Yan LI ; Pei HU
Acta Pharmaceutica Sinica 2015;50(5):541-546
The work aims to study the drug metabolizing enzymes involved in the metabolism of butylphthalide and evaluate the induction and inhibition activities of butylphthalide on CYP450 isoenzymes by using in vitro (liver microsome incubation system of rats and human) and in vivo (CYP induced model of rats) method. Butylphthalide was incubated with selective inhibitors of CYP450, and its metabolic rate was determined to identify the metabolizing isoenzymes of NBP in rat (normal and induced rats) and human liver microsomes. The in vitro inhibition effect of butylphthalide on 6 main liver microsomal CYP450 isoenzymes was evaluated by using probe drugs; the induction and inhibition activities in vivo of butylphthalide on CYP450 isoenzymes were evaluated by NBP ig dosing (160 mg x kg(-1)) and iv dosing (20 mg x kg(-1)) in rats. After adding the specific inhibitors of CYP2C11, 2E1 and 3A 1/2 for rat, CYP2C19, 2E1 and 3A4/5 for human, the metabolism of NBP in rat and human liver microsomes were reduced 38.8%, 86.2%, 78.4% and 51.0%, 92.0%, 58.9% of control, respectively. The metabolic rates of NBP in CYP2E1 and 3A 1/2 induced rat liver microsomes were increased 25.5% and 68.9%. High concentration of NBP (≥ 200 μmol x L(-1), in vitro) could inhibit the activities of CYP1A2, 2C6, 2C11 and 2D2 in rats, and high concentration of NBP ( ≥ 15 μmol x L(-1), in vitro) could inhibit the activity of CYP2C19 in human. All the results indicated that NBP should be mainly metabolized by CYP2E1, 2C11 and 3A 1/2 in rats and CYP2E1, 2C19 and 3A4/5 in human. High concentration of NBP could inhibit human CYP2C19 in vitro. No significant induction/inhibition effects of NBP were observed on rat liver CYP450 isoforms after ig 160 mg x kg(-1) NBP or iv 20 mg x kg(-1) NBP.
Animals
;
Benzofurans
;
pharmacology
;
Cytochrome P-450 Enzyme Inhibitors
;
pharmacology
;
Cytochrome P-450 Enzyme System
;
metabolism
;
Humans
;
Isoenzymes
;
metabolism
;
Liver
;
metabolism
;
Microsomes, Liver
;
metabolism
;
Rats
10.The function and meaning of receptor activator of NF-κB ligand in arterial calcification.
Bin NIE ; Shao-qiong ZHOU ; Xin FANG ; Shao-ying ZHANG ; Si-ming GUAN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2015;35(5):666-671
Osteoclast-like cells are known to inhibit arterial calcification. Receptor activator of NF-κB ligand (RANKL) is likely to act as an inducer of osteoclast-like cell differentiation. However, several studies have shown that RANKL promotes arterial calcification rather than inhibiting arterial calcification. The present study was conducted in order to investigate and elucidate this paradox. Firstly, RANKL was added into the media, and the monocyte precursor cells were cultured. Morphological observation and Tartrate resistant acid phosphatase (TRAP) staining were used to assess whether RANKL could induce the monocyte precursor cells to differentiate into osteoclast-like cells. During arterial calcification, in vivo and in vitro expression of RANKL and its inhibitor, osteoprotegerin (OPG), was detected by real-time PCR. The extent of osteoclast-like cell differentiation was also assessed. It was found RANKL could induce osteoclast-like cell differentiation. There was no in vivo or in vitro expression of osteoclast-like cells in the early stage of calcification. At that time, the ratio of RANKL to OPG was very low. In the late stage of calcification, a small amount of osteoclast-like cell expression coincided with a relatively high ratio of RANKL to OPG. According to the results, the ratio of RANKL to OPG was very low during most of the arterial calcification period. This made it possible for OPG to completely inhibit RANKL-induced osteoclast-like cell differentiation. This likely explains why RANKL had the ability to induce osteoclast-like cell differentiation but acted as a promoter of calcification instead.
Acid Phosphatase
;
genetics
;
metabolism
;
Animals
;
Aorta
;
drug effects
;
metabolism
;
pathology
;
Cell Differentiation
;
Coculture Techniques
;
Gene Expression Regulation
;
Isoenzymes
;
genetics
;
metabolism
;
Male
;
Monocytes
;
cytology
;
drug effects
;
metabolism
;
Myocytes, Smooth Muscle
;
drug effects
;
metabolism
;
pathology
;
Osteoclasts
;
drug effects
;
metabolism
;
pathology
;
Osteoprotegerin
;
genetics
;
metabolism
;
RANK Ligand
;
genetics
;
metabolism
;
pharmacology
;
Rats
;
Rats, Sprague-Dawley
;
Signal Transduction
;
Tartrate-Resistant Acid Phosphatase
;
Vascular Calcification
;
genetics
;
metabolism
;
pathology

Result Analysis
Print
Save
E-mail